Literature DB >> 25274991

Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare.

Aurélie Renvoisé1, Christine Bernard1, Nicolas Veziris1, Eve Galati2, Vincent Jarlier1, Jérôme Robert3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25274991      PMCID： PMC4313332          DOI： 10.1128/JCM.02127-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  11 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  Evaluation of the new GenoType Mycobacterium assay for identification of mycobacterial species.

Authors:  Cristina Russo; Enrico Tortoli; Donato Menichella
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

Review 3.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

4.  Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period.

Authors:  Yoshihiro Kobashi; Masaaki Abe; Keiji Mouri; Yasushi Obase; Shigeki Kato; Mikio Oka
Journal:  J Infect Chemother       Date:  2011-12-17       Impact factor: 2.211

5.  Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients.

Authors:  M Dailloux; M L Abalain; C Laurain; L Lebrun; C Loos-Ayav; A Lozniewski; J Maugein
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

6.  Commercial DNA probes for mycobacteria incorrectly identify a number of less frequently encountered species.

Authors:  Enrico Tortoli; Monica Pecorari; Giuliana Fabio; Massimino Messinò; Anna Fabio
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

7.  Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST.

Authors:  Michael Hombach; Akos Somoskövi; Rico Hömke; Claudia Ritter; Erik C Böttger
Journal:  Int J Med Microbiol       Date:  2013-04-26       Impact factor: 3.473

8.  Identification and partial characterization of Mycobacterium avium and Mycobacterium intracellulare by using DNA probes.

Authors:  H Saito; H Tomioka; K Sato; H Tasaka; M Tsukamura; F Kuze; K Asano
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

Review 9.  Diagnosis of nontuberculous mycobacterial infections.

Authors:  Jakko van Ingen
Journal:  Semin Respir Crit Care Med       Date:  2013-03-04       Impact factor: 3.119

10.  In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.

Authors:  Barbara A Brown-Elliott; Elena Iakhiaeva; David E Griffith; Gail L Woods; Jason E Stout; Cameron R Wolfe; Christine Y Turenne; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2013-08-14       Impact factor: 5.948
View more
  3 in total

1.  Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex.

Authors:  Aurélie Renvoisé; Florence Brossier; Eve Galati; Nicolas Veziris; Wladimir Sougakoff; Alexandra Aubry; Jérôme Robert; Emmanuelle Cambau; Vincent Jarlier; Christine Bernard
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

2.  Non-tuberculous mycobacterial infection in hospitalized children: a case series.

Authors:  P Y Iroh Tam; S Kline; G Ward; P Ferrieri
Journal:  Epidemiol Infect       Date:  2015-03-12       Impact factor: 4.434

3.  Rational Choice of Antibiotics and Media for Mycobacterium avium Complex Drug Susceptibility Testing.

Authors:  Jérémy Jaffré; Alexandra Aubry; Thomas Maitre; Florence Morel; Florence Brossier; Jérôme Robert; Wladimir Sougakoff; Nicolas Veziris
Journal:  Front Microbiol       Date:  2020-02-19       Impact factor: 5.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.